Biotech · Private company
Andover Research Eye Institute
Track this companyFree. Adds Andover Research Eye Institute to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- Fluticasone PropionateAllergic ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
- loratadine 10 mgAllergic ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
- olopatadine hydrochloride ophthalmic solution 0.7%)Allergic ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
- Preservative Free Polyethylene glycol 400 0.25%Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- Propylene Glycol (0.6%)Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- Tears NaturaleAllergic ConjunctivitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye DiseasePHASE4 · RECRUITING · started Jun 3, 2026ClinicalTrials.gov NCT07676084 · fetched Nov 12, 2026
- Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye DropsNA · COMPLETED · started Dec 12, 2022ClinicalTrials.gov NCT05660681 · fetched Nov 12, 2026
- A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic ConjunctivitisPHASE4 · COMPLETED · started Dec 31, 2021ClinicalTrials.gov NCT05314621 · fetched Nov 12, 2026
- A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic ConjunctivitisPHASE4 · COMPLETED · started Dec 14, 2021ClinicalTrials.gov NCT05265910 · fetched Nov 12, 2026